We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$16.4B
AUM Growth
+$1.76B
Cap. Flow
+$963M
Cap. Flow %
5.86%
Top 10 Hldgs %
36.55%
Holding
2,213
New
752
Increased
404
Reduced
406
Closed
645

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$276M
2
AAPL icon
Apple
AAPL
+$180M
3
DUK icon
Duke Energy
DUK
+$75.7M
4
COP icon
ConocoPhillips
COP
+$73.6M
5
AVGO icon
Broadcom
AVGO
+$70.4M

Sector Composition

Rank Sector Weight
1 Healthcare 11.11%
2 Technology 9.83%
3 Utilities 6.25%
4 Real Estate 4.8%
5 Consumer Discretionary 4.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
1501
PUT
Boeing
BA
$169B
$122K ﹤0.01%
800
-71,200
-99% -$12.2M
CERS icon
1502
Cerus
CERS
$566M
$120K ﹤0.01%
+69,184
New +$145K
KOS icon
1503
Kosmos Energy
KOS
$1.76B
$119K ﹤0.01%
29,433
-102,739
-78% -$500K
RXT icon
1504
Rackspace Technology
RXT
$846M
$116K ﹤0.01%
+47,216
New +$114K
QUIK icon
1505
QuickLogic
QUIK
$210M
$115K ﹤0.01%
+14,956
New +$138K
SMXT icon
1506
Solarmax Technology
SMXT
$17.3M
$115K ﹤0.01%
+15,154
New +$479K
QURE icon
1507
uniQure
QURE
$3.36B
$113K ﹤0.01%
+22,963
New +$150K
VERU icon
1508
Veru
VERU
$45M
$109K ﹤0.01%
+14,238
New +$123K
VERV
1509
DELISTED
Verve Therapeutics
VERV
$108K ﹤0.01%
+22,227
New +$129K
CHGG icon
1510
Chegg
CHGG
$90.8M
$105K ﹤0.01%
+59,076
New +$145K
DIBS icon
1511
1stdibs.com
DIBS
$160M
$104K ﹤0.01%
+23,647
New +$107K
TTEC icon
1512
TTEC Holdings
TTEC
$67.5M
$98K ﹤0.01%
+16,724
New +$91.2K
SKYE icon
1513
Skye Bioscience
SKYE
$1.24M
$96K ﹤0.01%
+3,069
New +$138K
EYPT icon
1514
EyePoint Inc
EYPT
$459M
$92K ﹤0.01%
+11,468
New +$101K
GAUZ
1515
Gauzy
GAUZ
$9.13M
$92K ﹤0.01%
10,367
-19,531
-65% -$199K
LUMN icon
1516
Lumen
LUMN
$6.13B
$90K ﹤0.01%
+12,717
New +$54.3K
AIOT
1517
PowerFleet Inc
AIOT
$408M
$86K ﹤0.01%
+17,134
New +$81.4K
GCTS
1518
GCT Semiconductor Holding
GCTS
$188M
$85K ﹤0.01%
+25,335
New +$95.6K
LVO icon
1519
LiveOne
LVO
$54.4M
$84K ﹤0.01%
+8,849
New +$133K
POWW icon
1520
Outdoor Holding Co
POWW
$260M
$84K ﹤0.01%
+58,776
New +$93.1K
GALT icon
1521
Galectin Therapeutics
GALT
$371M
$81K ﹤0.01%
+29,552
New +$72.6K
ORLA
1522
DELISTED
Orla Mining
ORLA
$81K ﹤0.01%
+20,224
New +$80.1K
PBYI icon
1523
Puma Biotechnology
PBYI
$477M
$79K ﹤0.01%
+30,905
New +$93.5K
WEST icon
1524
Westrock Coffee
WEST
$812M
$74K ﹤0.01%
+11,387
New +$100K
RDNW
1525
RideNow Group
RDNW
$233M
$71K ﹤0.01%
+14,817
New +$61.2K

Similar funds

Michael Gelband's Q3 2024 Portfolio in Review

As of Q3 2024, Michael Gelband held 2,213 positions worth $16.4B, up 12% from $14.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Michael Gelband deployed $963M of net new capital in Q3 2024, opening 752 new positions and adding to 404 existing holdings. Its largest new stake was Mondelez International: 1,784,906 shares worth $131M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 10% a quarter earlier, followed by Technology and Utilities.

On the sell side, the largest reduction was ConocoPhillips, an estimated $73.6M trimmed.

  • Michael Gelband's largest Q3 2024 buy was Mondelez International: 1,784,906 shares worth $131M.
  • Michael Gelband added most to Microsoft in Q3 2024, an estimated $384M increase.
  • Michael Gelband's biggest Q3 2024 reduction was ConocoPhillips, cutting an estimated $73.6M.
  • Michael Gelband fully exited Amazon in Q3 2024, selling an estimated $276M.
  • Michael Gelband's ten largest holdings make up 37% of its $16.4B portfolio in Q3 2024.
  • Michael Gelband opened 752 new positions and closed 645 in Q3 2024.
  • Michael Gelband's portfolio value rose 12% quarter-over-quarter to $16.4B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.